Weiss Asset Management’s Soleno Therapeutics SLNO Stock Holding History

Weiss Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23,000	Closed	-$770K	–	818
2026 Q1	$770K	Buy	+23,000	New	+$902K	0.01%	363

Weiss Asset Management's SLNO Position: Q2 2026 in Review

Weiss Asset Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 23,000 shares — an estimated $770K sold.

Weiss Asset Management first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $770K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Weiss Asset Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Weiss Asset Management sold 23,000 Soleno Therapeutics shares in Q2 2026, an estimated $770K.
Weiss Asset Management first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Weiss Asset Management's Soleno Therapeutics position peaked at $770K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.